MUFG Securities EMEA’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.55M | Hold |
233,159
| – | – | 0.1% | 140 |
|
|
2025
Q4 | $5.81M | Buy |
233,159
+124,334
| +114% | +$3.14M | 0.07% | 186 |
|
|
2025
Q3 | $2.77M | Buy |
108,825
+92,025
| +548% | +$2.27M | 0.07% | 136 |
|
|
2025
Q2 | $407K | Sell |
16,800
-379,199
| -96% | -$8.84M | 0.02% | 146 |
|
|
2025
Q1 | $10M | Sell |
395,999
-476,100
| -55% | -$12.5M | 0.23% | 44 |
|
|
2024
Q4 | $23.1M | Buy |
+872,099
| New | +$23.7M | 0.39% | 40 |
|
|
2024
Q3 | – | Sell |
-572
| Closed | -$16K | – | 183 |
|
|
2024
Q2 | $16K | Hold |
572
| – | – | ﹤0.01% | 119 |
|
|
2024
Q1 | $15.9K | Sell |
572
-700,428
| -100% | -$19.4M | ﹤0.01% | 65 |
|
|
2023
Q4 | $20.2M | Buy |
701,000
+700,000
| +70,000% | +$21.2M | 1.19% | 31 |
|
|
2023
Q3 | $33.2K | Sell |
1,000
-3,737
| -79% | -$132K | ﹤0.01% | 90 |
|
|
2023
Q2 | $174K | Buy |
4,737
+3,737
| +374% | +$145K | ﹤0.01% | 102 |
|
|
2023
Q1 | $41K | Hold |
1,000
| – | – | ﹤0.01% | 108 |
|
|
2022
Q4 | $51K | Hold |
1,000
| – | – | ﹤0.01% | 156 |
|
|
2022
Q3 | $44K | Hold |
1,000
| – | – | ﹤0.01% | 129 |
|
|
2022
Q2 | $52K | Sell |
1,000
-1,052,400
| -100% | -$53.6M | ﹤0.01% | 116 |
|
|
2022
Q1 | $54.5M | Sell |
1,053,400
-547,600
| -34% | -$28.4M | 0.9% | 16 |
|
|
2021
Q4 | $94.5M | Buy |
1,601,000
+301,507
| +23% | +$14.9M | 1.4% | 13 |
|
|
2021
Q3 | $55.9M | Sell |
1,299,493
-1,328,138
| -51% | -$58.8M | 0.63% | 35 |
|
|
2021
Q2 | $103M | Sell |
2,627,631
-88,710
| -3% | -$3.45M | 0.98% | 16 |
|
|
2021
Q1 | $98.4M | Buy |
2,716,341
+1,401,557
| +107% | +$49.8M | 0.8% | 23 |
|
|
2020
Q4 | $48.4M | Sell |
1,314,784
-335,865
| -20% | -$12.3M | 0.37% | 51 |
|
|
2020
Q3 | $57.5M | Buy |
1,650,649
+277,833
| +20% | +$9.74M | 0.55% | 31 |
|
|
2020
Q2 | $42.6M | Sell |
1,372,816
-1,240,102
| -47% | -$42.1M | 0.37% | 56 |
|
|
2020
Q1 | $80.9M | Buy |
2,612,918
+793,082
| +44% | +$27M | 0.82% | 20 |
|
|
2019
Q4 | $67.6M | Buy |
1,819,836
+985,002
| +118% | +$35.1M | 0.53% | 30 |
|
|
2019
Q3 | $28.5M | Sell |
834,834
-782,661
| -48% | -$28.5M | 0.34% | 54 |
|
|
2019
Q2 | $66.5M | Buy |
1,617,495
+291,563
| +22% | +$11.6M | 0.7% | 28 |
|
|
2019
Q1 | $53.4M | Buy |
1,325,932
+560,306
| +73% | +$22.4M | 0.62% | 30 |
|
|
2018
Q4 | $31.7M | Sell |
765,626
-410,553
| -35% | -$17M | 0.32% | 48 |
|
|
2018
Q3 | $49.2M | Buy |
1,176,179
+494,713
| +73% | +$19M | 0.7% | 25 |
|
|
2018
Q2 | $23.5M | Sell |
681,466
-293,484
| -30% | -$10M | 0.43% | 41 |
|
|
2018
Q1 | $32.8M | Sell |
974,950
-2,345,150
| -71% | -$80.6M | 0.7% | 24 |
|
|
2017
Q4 | $114M | Buy |
3,320,100
+2,476,900
| +294% | +$84.5M | 2.65% | 3 |
|
|
2017
Q3 | $28.6M | Buy |
+843,200
| New | +$27.1M | 1.02% | 19 |
|
|
2014
Q2 | – | Sell |
-263,500
| Closed | -$8.03M | – | 124 |
|
|
2014
Q1 | $8.03M | Buy |
+263,500
| New | +$7.86M | 1.75% | 18 |
|
Other funds holding PFE
VCM
VPM
MUFG Securities EMEA's PFE Position: Q1 2026 in Review
MUFG Securities EMEA held its Pfizer (PFE) position steady in Q1 2026 at 233,159 shares worth $6.55M. The position accounts for 0.1% of the portfolio, ranked #140.
MUFG Securities EMEA first reported a position in PFE in Q1 2014 and has held it in 35 quarters since. The position peaked at $114M in Q4 2017. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- MUFG Securities EMEA held 233,159 shares of Pfizer worth $6.55M as of Q1 2026.
- MUFG Securities EMEA left its Pfizer share count unchanged in Q1 2026.
- Pfizer made up 0.1% of MUFG Securities EMEA's portfolio in Q1 2026, its #140 holding.
- MUFG Securities EMEA first reported a position in Pfizer in Q1 2014 and has held it in 35 quarters since.
- MUFG Securities EMEA's Pfizer position peaked at $114M in Q4 2017.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on MUFG Securities EMEA's 13F filing for Q1 2026, filed 11 May 2026.